- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-289/09: Judgment of the General Court of 9 September 2011 — Omnicare v OHIM — Astellas Pharma (OMNICARE CLINICAL RESEARCH) (Community trade mark — Opposition proceedings — Application for Community word mark OMNICARE CLINICAL RESEARCH — Earlier national figurative mark OMNICARE — Likelihood of confusion — Similarity of the signs — Similarity of the services — Genuine use of the earlier mark)
ECLI:EU:UNKNOWN:62009TA0289
62009TA0289
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
22.10.2011
Official Journal of the European Union
C 311/41
(Case T-289/09)(<span class="super">1</span>)
(Community trade mark - Opposition proceedings - Application for Community word mark OMNICARE CLINICAL RESEARCH - Earlier national figurative mark OMNICARE - Likelihood of confusion - Similarity of the signs - Similarity of the services - Genuine use of the earlier mark)
2011/C 311/74
Language of the case: English
Parties
Applicant: Omnicare, Inc. (Covington, Kentucky, United States) (represented by: M. Edenborough QC)
Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: J. Crespo Carrillo, Agent)
Other party to the proceedings before the Board of Appeal of OHIM, intervening before the General Court: Astellas Pharma GmbH (Munich, Germany) (represented by: C. Gutiérrez Martínez, H. Granado Carpenter and M. Polo Carreño, lawyers)
Re:
Action brought against the decision of the Fourth Board of Appeal of OHIM of 14 May 2009 (Case R 401/2008-4), concerning opposition proceedings between Yamanouchi Pharma GmbH and Omnicare, Inc.
Operative part of the judgment
The Court:
1.Dismisses the action;
2.Orders Omnicare, Inc. to pay the costs.
(<span class="super">1</span>) OJ C 244, 10.10.2009.